Abstract:It is important to characterize the temporal trajectories of disease-related biomarkers in order to monitor progression and identify potential points of intervention. These are especially important for neurodegenerative diseases, as therapeutic intervention is most likely to be effective in the preclinical disease stages prior to significant neuronal damage. Neuroimaging allows for the measurement of structural, functional, and metabolic integrity of the brain at the level of voxels, whose volumes are on the order of mm(3). These voxelwise measurements provide a rich collection of disease indicators. Longitudinal neuroimaging studies enable the analysis of changes in these voxelwise measures. However, commonly used longitudinal analysis approaches, such as linear mixed effects models, do not account for the fact that individuals enter a study at various disease stages and progress at different rates, and generally consider each voxelwise measure independently. We propose a multivariate nonlinear mixed effects model for estimating the trajectories of voxelwise neuroimaging biomarkers from longitudinal data that accounts for such differences across individuals. The method involves the prediction of a progression score for each visit based on a collective analysis of voxelwise biomarker data within an expectation-maximization framework that efficiently handles large amounts of measurements and variable number of visits per individual, and accounts for spatial correlations among voxels. This score allows individuals with similar progressions to be aligned and analyzed together, which enables the construction of a trajectory of brain changes as a function of an underlying progression or disease stage. We apply our method to studying cortical β-amyloid deposition, a hallmark of preclinical Alzheimer's disease, as measured using positron emission tomography. Results on 104 individuals with a total of 300 visits suggest that precuneus is the earliest cortical region to accumulate amyloid, closely followed by the cingulate and frontal cortices, then by the lateral parietal cortex. The extracted progression scores reveal a pattern similar to mean cortical distribution volume ratio (DVR), an index of global brain amyloid levels. The proposed method can be applied to other types of longitudinal imaging data, including metabolism, blood flow, tau, and structural imaging-derived measures, to extract individualized summary scores indicating disease progression and to provide voxelwise trajectories that can be compared between brain regions.

Penalized nonlinear mixed effects model to identify biomarkers that predict disease progression

A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging

Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers

Predicting the progression of Parkinson's disease using conventional MRI and machine learning: An application of radiomic biomarkers in whole-brain white matter

Modelling the Natural History of Huntington'S Disease Progression

Predicting the multi-domain progression of Parkinson’s disease: a Bayesian multivariate generalized linear mixed-effect model

Predicting Cognitive Declines Using Longitudinally Enriched Representations For Imaging Biomarkers

Robust parametric modeling of Alzheimer's disease progression

Dynamic Prediction for Multiple Repeated Measures and Event Time Data: An Application to Parkinson's Disease

Multi-predictor modeling for predicting early Parkinson's disease and non-motor symptoms progression

Identification of Genetic Risk Factors Based on Disease Progression Derived from Longitudinal Brain Imaging Phenotypes.

Probabilistic Clustering using Shared Latent Variable Model for Assessing Alzheimers Disease Biomarkers

Disease progression modelling of Alzheimer's disease using probabilistic principal components analysis

Early diagnosis and clinical score prediction of Parkinson's disease based on longitudinal neuroimaging data

A Probabilistic Disease Progression Model for Predicting Future Clinical Outcome

Modeling disease progression via multi-task learning

Personalized Progression Modelling and Prediction in Parkinson’s Disease with a Novel Multi-Modal Graph Approach

Disease Progression Modeling and Prediction through Random Effect Gaussian Processes and Time Transformation

Alzheimer's Disease Progression Model Based on Integrated Biomarkers and Clinical Measures

Probabilistic prediction of neurological disorders with a statistical assessment of neuroimaging data modalities

Machine learning on longitudinal multi-modal data enabling the understanding and prognosis of Alzheimer’s disease progression